Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 14, 2026, 12:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 3,924 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Respiratory Tract Infections (RTI) Clear all

Conditions: Asthma
Interventions: OMT, Light touch; Procedure · Other
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Mayfield Heights, Ohio

Conditions: Aspiration Pneumonia
Interventions: smART Feeding Tube System; Device
Lead sponsor: ART Medical Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: COVID-19 Pandemic, Health Knowledge, Attitudes, Practice, Perinatal Depression, Mental Health Wellness, Post Partum Depression
Interventions: Baby2Home Mobile Application; Other
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years and older
Enrollment: 642 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois • Providence, Rhode Island

Conditions: Pneumonia
Interventions: Not listed
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years and older
Enrollment: 278 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Chronic Rhinitis
Interventions: NEUROMARK™ System, Sham Device; Device
Lead sponsor: Neurent Medical; Industry
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Birmingham, Alabama • Roseville, California • Colorado Springs, Colorado + 5 more

Conditions: COVID-19
Interventions: ALG-097558; Drug
Lead sponsor: Aligos Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Miami, Florida • Orlando, Florida

Conditions: Pneumonia
Interventions: Physician Survey, ePNa-CheXED; Other · Device
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 12 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 12
States / cities: American Fork, Utah • Layton, Utah • Lehi, Utah + 9 more

Conditions: Seasonal Influenza
Interventions: mRNA-1011.1, mRNA-1011.2, mRNA-1012.1, mRNA-1010, mRNA-1010.2, mRNA-1010.3; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 698 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 22
States / cities: Lakewood, California • Long Beach, California • Fort Collins, Colorado + 19 more

Conditions: Influenza
Interventions: High-Fiber Diet (HFD), Prebiotic Food-Enriched Diet (PreFED); Dietary Supplement
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Respiratory Distress Syndrome, Adult, Sars-CoV2
Interventions: Hypothermia, Neuromuscular Blocking Agents, Standard of Care; Device · Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pneumonia, Blood Stream Infection
Interventions: colistin and meropenem, colistin and placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 95 Years
Enrollment: 467 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 6
States / cities: Miami, Florida • Detroit, Michigan • Royal Oak, Michigan + 2 more

Conditions: Covid19
Interventions: COVID-19 Testing; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 4,733 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Covid19
Interventions: Selenium (as Selenious Acid), Placebo; Drug · Other
Lead sponsor: CHRISTUS Health; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Longview, Texas

Conditions: Coronavirus Disease (COVID-19)
Interventions: V590, Placebo; Biological · Other
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 232 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Tempe, Arizona • Miami, Florida • South Miami, Florida + 4 more

Conditions: Respiratory Infections
Interventions: Release of test results; Other
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Pertussis
Interventions: Pentacel® (DTaP-IPV/Hib), Other Pertussis Vaccines; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: Up to 59 Months
Enrollment: 1,195 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: COVID-19
Interventions: Facilitated Self-Sampling Intervention (FSSI), Testing Navigation Intervention (TNI)., Control; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 1,232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Brownsville, Texas • Houston, Texas • Tyler, Texas

Conditions: Influenza
Interventions: Baloxavir Marboxil; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: Up to 1 Year
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 8
States / cities: Jonesboro, Arkansas • Tampa, Florida • Idaho Falls, Idaho + 5 more

Conditions: Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
Interventions: 7% hypertonic saline; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 82 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Pneumonia
Interventions: Tifacogin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: Not listed
Enrollment: 2,136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 51
States / cities: Mobile, Alabama • Loma Linda, California • Los Angeles, California + 48 more

Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections
Interventions: Pentamidine isethionate; Drug
Lead sponsor: Fisons; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Chicago, Illinois • Boston, Massachusetts

Conditions: Brain Diseases, Covid19
Interventions: Injected radiotracer with PET Insert; Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 21 Years and older
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: COVID-19, COVID-19 Pandemic
Interventions: COVID-19 walk-up, on-site testing strategy, Community Health Worker (CHW) leading testing navigation and general preventive care reminders, No-cost self-testing kit vending machines; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: Not listed
Enrollment: 6,527 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Ysidro, California

Conditions: Influenza
Interventions: FluMist, Fluzone; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 5 Years to 9 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Asthma and Osteopathic Manipulative Technique

Functionality and Accuracy of the smART System in Real-Life ICU Settings

Baby2Home (B2H) Mobile Health Application

Vancomycin De-escalation Therapy in Patients With Pneumonia

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Impact of High Dietary Fiber on Microbiome and Vaccine Responses

Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

Test to Stay in School: COVID-19 Testing Following Exposure in School Communities

Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.

Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)

Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease

Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia

A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP

Pilot Study for PET/MR Imaging of Covid-19

Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment